News

Bendamustine hydrochloride is a ready-to-dilute concentrate solution for injection that will be administered by infusion over 10 minutes after dilution in 50mL of sodium chloride (saline) or a

This USPTO issuance, combined with a similar success for a Chinese patent (ZL 200880124132.8) provides a solid foundation and protection for the company’s leading siRNA therapeutic project under

The company intends to initiate shipments of the product prior to the upcoming cough/cold/flu season. Advil Congestion Relief Tablets, 200mg/10mg, (ibuprofen & phenylephrine hydrochloride tablets, 200mg/10mg) is indicated

A new drug application was filed for the nonsteroidal anti-inflammatory drug (NSAID) with the Republic of Lebanon Ministry of Public Health (MOPH). ZORVOLEX was approved by the U.S.

The Company’s strategic research plan is designed to establish a series of inflammation assays and models with the goal of developing a hemp-extract profiling platform. This platform will

This second MJFF grant will be used to fund the Company’s CTH-105 clinical study. APL-130277 is an easy-to-administer, fast-acting and proprietary reformulation of apomorphine for sublingual delivery. Injectable

Actavis’ ANDA product is a generic version of Acorda Therapeutics’ Ampyra, which is indicated as a treatment to improve walking in patients with multiple sclerosis. Acorda Therapeutics, Inc.

The FDA acceptance follows the acceptance of the marketing authorization dossier for Toujeo by the European Medicines Agency (EMA) for EU countries in May 2014. The new drug

GelStat acquired 100% of the membership equity in Mastix Medica, LLC in exchange for 27,500,000 restricted shares in GelStat’s common stock. In conjunction with the closing of this